Cargando…
First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients
(68)Ga-NOTA-WL12 is a peptide-based PET imaging agent. We conducted a first-in-human study of (68)Ga-NOTA-WL12 for PET to study the in vivo biodistribution, metabolism, radiation dosimetry, safety, and potential for quantifying programmed death ligand-1 (PD-L1) expression levels in patients with adv...
Autores principales: | Zhou, Xin, Jiang, Jinquan, Yang, Xue, Liu, Teli, Ding, Jin, Nimmagadda, Sridhar, Pomper, Martin G., Zhu, Hua, Zhao, Jun, Yang, Zhi, Li, Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Nuclear Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973283/ https://www.ncbi.nlm.nih.gov/pubmed/34326125 http://dx.doi.org/10.2967/jnumed.121.262045 |
Ejemplares similares
-
Peptide-Based (68)Ga-PET Radiotracer for
Imaging PD-L1 Expression in Cancer
por: De Silva, Ravindra A., et al.
Publicado: (2018) -
Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors
por: Li, Li, et al.
Publicado: (2022) -
Dynamic PET/CT Imaging of (68)Ga-FAPI-04 in Chinese Subjects
por: Wang, Shuailiang, et al.
Publicado: (2021) -
Development of [(18)F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide
por: Lesniak, Wojciech G., et al.
Publicado: (2019) -
The next era of renal radionuclide imaging: novel PET radiotracers
por: Werner, Rudolf A., et al.
Publicado: (2019)